Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius SE & Co. KGaA

Investor Presentation • Sep 13, 2013

166_ip_2013-09-13_0f8b5a41-469b-44fb-b9d9-c840170f2765.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

Acquiring 43 Hospitals from Rhön-Klinikum AG

Conference Call, September 13, 2013

Safe Harbor Statement

This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements contained in this presentation.

Compelling Strategic Rationale

U
i
i
t
t
n
q
e
o
p
p
o
r
n
u
u
y
i
h
i
h
l
t
o
a
c
q
u
r
e
g
y
i
l
i
i
t
t
t
a
r
a
c
v
e
c
n
c
f
l
i
t
p
o
r
o
o		 h
i
l
b
d
i
f
i
l
i
i
4
3
t
1
1
8
0
0
1
5
t
t
t
t
o
s
p
a
s,
a
p
p
r
o
x
e
s,
o
u
p
a
e
n
a
c
e
s
-
,
€
2
b
l
d
€
2
5
0
E
B
I
T
D
A
i
2
0
1
3
d
t
n
s
a
e
s
a
n
m
n
e
x
p
e
c
e
~
-
P
f
i
t
t
t
e
r
e
c
s
r
a
e
g
c
d
h
i
f
i
t
a
n
g
e
o
g
r
a
p
c		 E
b
l
i
h
l
i
d
k
i
h
h
i
l
d
t
t
t
t
t
1
1
7
t
s
a
s
a
r
g
e
s
c
o
n
r
e
n
e
o
r
o
s
p
a
s
a
n
u
y
w
w
w
-
(
)
b
l
f
€
5
5
2
0
1
3
n
s
a
e
s
e
p
r
o
o
r
m
a
~
M
j
i
f
h
G
l
i
i
l
l
h
H
E
L
I
O
S
t
t
t
t
a
o
r
o
e
e
r
m
a
n
p
o
p
a
o
n
a
e
a
c
c
e
s
s
o
a
y
u
w
v
-
h
i
l
i
h
i
h
d
i
t
t
's
o
s
p
a
w
n
o
n
e
o
u
r
r
v
e
S
i
i
f
i
l
t
g
n
c
a
n
a
e
v
u
i
t
c
r
e
a
o
n		 B
i
l
d
H
E
L
I
O
S
f
l
i
i
k
d
t
t
t
'
u
o
n
s
u
c
c
e
s
s
u
n
e
g
r
a
o
n
r
a
c
r
e
c
o
r
-
h
i
f
f
i
i
i
E
t
n
a
n
c
e
o
p
e
r
a
n
g
e
c
e
n
c
e
s
-
E
b
l
i
h
i
d
t
t
t
t
t
s
a
s
n
e
g
r
a
e
c
a
r
e
s
r
c
r
e
s
u
u
-
i
i
l
l
d
F
n
a
n
c
a
y
s
o
u
n
i
i
i
t
a
c
q
s
o
n
u		 (
)
E
d
b
E
P
S
i
i
h
f
i
l.
i
t
t
t
t
t
t
t
x
p
e
c
e
o
e
a
c
c
r
e
v
e
n
e
r
s
y
e
a
r
e
x
c
o
n
e
m
e
c
o
s
s
-
-
F
l
l
d
b
f
i
d
t-
e
n
a
n
c
e
u
y
-

Perfect Geographic Fit – HELIOS Hospital Network Pro Forma

    • Creating Europe's largest hospital operator with ~€5.51 bn sales and >€750 m1 EBITDA
    • Majority of the German population have access to a HELIOS hospital within one hour's drive
  • -7 maximum-care hospitals
  • -84 advanced-care / basic-care hospitals
  • -26 rehabilitation clinics
  • -50 outpatient facilities
    • University hospital Giessen/Marburg, and hospitals in Bad Neustadt, Bad Berka, Frankfurt/Oder not part of the acquisition

1Pro forma 2013e

Conference Call, Fresenius SE & Co. KGaA, Investor Relations © Copyright, September 13, 2013 Page 4

Substantial Synergies and Operating Efficiencies

T
i
m
e		 E
f
f
t
e
c
S
h
t-
t
o
r
e
r
m		 A
€
8
i
b
f
b
2
0
5
t
1
5
p
p
r
o
m
s
n
e
r
g
e
s
p
a
e
o
r
e
a
x
y
x
y
(
)
%
i
i
l
i
f
l
5
0
t
e
g
n
c
r
e
a
s
e
n
p
r
o
c
u
r
e
m
e
n
v
o
u
m
e
s
e
c
o
n
o
m
e
s
o
s
c
a
e
;
f
l
d
h
i
l
d
l
l
t
t
t
r
o
n
o
a
s
o
s
p
a
e
v
e
o
p
m
e
n
p
a
n
-
d
i
l
d
l
l
i
i
k
t
t
e
a
e
p
a
n
o
w
e
r
s
e
x
e
c
u
o
n
r
s
-
O
i
f
b
f
f
f
l
€
8
0
P
L
t
t
t
&
t
t
n
e
m
e
c
o
s
s
o
a
p
p
r
o
x
m
e
o
r
e
a
x
e
e
c
m
o
s
y
;
-
i
2
0
1
4
n
i
d
M
t
e
r
m
-		 l
i
d
h
i
l
f
l
i
i
d
h
h
l
f
N
t
t
t
t
e
w
y
a
c
q
u
r
e
o
s
p
a
p
o
r
o
o
s
e
x
p
e
c
e
o
r
e
a
c
u
p
p
e
r
a
f
1
2–
1
%
E
B
I
T
i
i
l
i
i
h
H
E
L
I
O
S
h
i
l
5
t
t
t
t
'
o
m
a
r
g
n
a
r
g
e
n
n
e
w
o
s
p
a
d
l
l
t
e
v
e
o
p
m
e
n
p
a
n

Perfect Strategic Fit – Sources for Future Growth

German-wide Hospital Presence as a Key Prerequisite

i
T
m
e		 f
f
E
t
e
c
P
i
i
i
t
t
r
a
a
o
n
v
z
O
i
i
t
t
p
p
o
r
u
n
e
s		 S
l
i
h
d
b
d
i
l
t
t
e
e
c
v
e
a
p
p
r
o
a
c
u
e
o
r
o
a
r
e
g
o
n
a
p
r
e
s
e
n
c
e
;
(
f
€
i
l
l
i
l
i-
t
t
1
5
0
t
r
e
e
n
e
a
r
g
e
o
m
o
n
p
a
m
e
a
r
v
u
u
y
~
)
a
v
e
r
a
g
e
R
S
i
e
e
n
e
n
e
r
g
e
s
v
u
y		 Y
2
r
d
o
n
w
a
r
s		 /
I
d
i
i
b
i
d
t
t-
n
c
r
e
a
s
e
a
m
s
s
o
n
s,
e
g
c
o
m
n
e
a
c
u
e
p
o
s
f
f
i
t
a
c
u
e
c
a
r
e
o
e
r
n
g
D
l
i
d
t
t
t
t
t
t
e
e
o
p
n
e
g
r
a
e
c
a
r
e
s
r
c
r
e
s
o
s
p
p
o
r
v
u
u
u
i
h
t
t
o
r
g
a
n
c
g
r
o
w
m
o
m
e
n
u
m
–
t
1
H
E
L
I
O
S
C
L
U
B
l
h
d
t
t
s
s
e
p
c
o
n
c
e
p
a
u
n
c
e
:

Additional growth opportunities – not included in financial model

Conference Call, Fresenius SE & Co. KGaA, Investor Relations © Copyright, September 13, 2013 Page 6

Financially Sound Acquisition

T
l
t
o
a
i
d
i
t
c
o
n
s
e
r
a
o
n		 (
)
d
b
f
€
3
0
7
0
t-
m
e
r
e
e
-
,
A
1
2
E
B
I
T
D
A
2
0
1
3
p
p
r
o
e
x
x
-
F
i
i
n
a
n
c
n
g		 0
0
%
d
b
f
i
i
1
t-
e
n
a
n
c
n
g
-
N
f
i
i
h
h
i
l
i
F
M
C
h
t
t
o
n
a
n
c
n
g
r
o
u
g
c
a
p
a
n
c
r
e
a
s
e
o
r
s
a
r
e
s
-
N
t
e
/
d
b
E
B
I
T
D
A
t
e		 2
0
3
f
3
0
3
1
5
p
r
o
o
r
m
a
x
:
:
-
-
d
f
2
0
1
4
2
5
3
0
u
p
p
e
r
e
n
o
x
r
a
n
g
e
:
-
-
E
i
a
r
n
n
g
s
p
e
r
S
h
a
r
e		 A
i
i
i
d
b
E
P
S
i
i
h
f
i
t
t
t
t
t
t
c
q
u
s
o
n
e
x
p
e
c
e
o
e
a
c
c
r
e
v
e
n
e
r
s
y
e
a
r
-
(
)
l.
i
d
l
l
i
f
h
t
t
t
t
e
x
c
o
n
e
m
e
c
o
s
s
a
n
c
e
a
r
y
a
c
c
r
e
v
e
r
o
m
e
-
(
)
d
d
i
l.
i
t
t
s
e
c
o
n
e
a
r
o
n
a
r
s
n
c
o
n
e
m
e
c
o
s
s
y
w
-

Share Information

Share key facts

Number of shares1 178,763,259 Ticker symbol FRE Bloomberg symbol FRE GR Reuters symbol FREG.de

WKN / ISIN 578560 / DE0005785604

ADR key facts

Ticker symbol FSNUY Exchange OTC-market Depositary bank Deutsche Bank

Ratio 8 ADRs = 1 ordinary share ADR CUSIP / ISIN 35804M105 / US35804M1053Structure Sponsored Level I ADR

1as of August 30, 2013

Conference Call, Fresenius SE & Co. KGaA, Investor Relations © Copyright, September 13, 2013 Page 8

Financial Calendar 2013

05.11.2013 Report on 1st – 3rd quarter 2013

Contact

Birgit Grund SVP Investor Relations Fresenius SE & Co. KGaA Telephone: +49 6172 608-2485

e-mail: [email protected]

For further information and current news: http://www.fresenius.com

More from Fresenius SE & Co. KGaA

Declaration of Voting Results & Voting Rights Announcements 2025
Nov 17
Declaration of Voting Results & Voting Rights Announcements 2025
Nov 14
Report Publication Announcement 2025
Nov 6
Quarterly Report 2025
Nov 6
Interim / Quarterly Report 2025
Aug 6
Investor Presentation 2025
Aug 6
Declaration of Voting Results & Voting Rights Announcements 2025
Jul 4
Declaration of Voting Results & Voting Rights Announcements 2025
Jun 20
Governance Information 2025
May 23
Quarterly Report 2025
May 7
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.